Signaturefd, LLC Morphic Holding, Inc. Transaction History

Signaturefd, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$26.64 - $40.31 $319 - $483	12 New	12 $0
Q3 2023 Nov 03, 2023	SELL	$21.33 - $59.42 $106 - $297	-5 Reduced 3.42%	141 $3,000
Q2 2023 Aug 01, 2023	SELL	$34.33 - $62.11 $755 - $1,366	-22 Reduced 13.1%	146 $8,000
Q1 2023 Apr 28, 2023	BUY	$26.01 - $48.69 $702 - $1,314	27 Added 19.15%	168 $6,000
Q4 2022 Jan 27, 2023	SELL	$24.14 - $30.37 $2,462 - $3,097	-102 Reduced 41.98%	141 $3,000
Q3 2022 Nov 08, 2022	BUY	$22.23 - $33.37 $2,267 - $3,403	102 Added 72.34%	243 $7,000
Q2 2022 Aug 10, 2022	BUY	$19.74 - $43.01 $2,783 - $6,064	141 New	141 $3,000
Q1 2022 May 02, 2022	SELL	$36.25 - $52.02 $145 - $208	-4 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$43.27 - $65.72 $173 - $262	4 New	4 $0
Q3 2021 Oct 28, 2021	SELL	$53.61 - $67.5 $696 - $877	-13 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$45.13 - $64.99 $586 - $844	13 New	13 $1,000

4.7M

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.